Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Three series of CGRP receptor antagonists claimed by Merck

Nov. 17, 2004

Merck patent claims bradykinin B1 receptor antagonist

Nov. 17, 2004

CCR2 receptor modulators described by Merck

Nov. 17, 2004

New histone deacetylase inhibitors in early development at Syrrx

Nov. 17, 2004

Medicure discloses cardioprotective agents

Nov. 16, 2004

Two series of oxazolidinone antibacterials claimed by AstraZeneca

Nov. 16, 2004

Roche patents non-nucleoside reverse transcriptase inhibitors

Nov. 16, 2004

Researchers at Wyeth describe compounds for the treatment of anxiety and depression

Nov. 16, 2004

Contrast agents described in patent literature

Nov. 16, 2004

PDE5 inhibitors for the treatment of diabetes

Nov. 16, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...